Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial

Gastroenterology

Volumn 149, Issue 1, 2015, Pages 102-109.e6

  Moayyedi, Paul ^a   Surette, Michael G ^a   Kim, Peter T ^b,c   Libertucci, Josie ^a   Wolfe, Melanie ^a   Onischi, Catherine ^c   Armstrong, David ^a   Marshall, John K ^a   Kassam, Zain ^d   Reinisch, Walter ^a   Lee, Christine H ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

Colon; IBD; Microbe; Treatment

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; ENEMA; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MESALAZINE; PLACEBO;

ABSCESS; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; COLITIS; COLON RESECTION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MICROBIAL DIVERSITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; SIGMOIDOSCOPY; TRANSPLANTATION; TREATMENT FAILURE; ULCERATIVE COLITIS; AGED; BIOLOGICAL THERAPY; COLITIS, ULCERATIVE; FECES; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES;

ADULT; AGED; BIOLOGICAL THERAPY; COLITIS, ULCERATIVE; FECES; FEMALE; HUMANS; MALE; MICROBIOTA; MIDDLE AGED; REMISSION INDUCTION;

EID: 84931469899     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.04.001     Document Type: Article

References (32)

1. M.D. Kappelman, S.L. Rifas-Shiman, and K. Kleinman The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States Clin Gastroenterol Hepatol 5 2007 1424 1429
2. S. Danese, and C. Fiocchi Ulcerative colitis N Engl J Med 365 2013 1713 1725
3. L.A. Graff, J.R. Walker, and I. Clara Stress coping, distress, and health perceptions in inflammatory bowel disease and community controls Am J Gastroenterol 104 2009 2959 2969
4. A.C. Ford, P. Moayyedi, and S.B. Hanauer Ulcerative colitis BMJ 346 2013 f432
5. N.J. Talley, M.T. Abreu, and J.P. Achkar An evidence-based systematic review on medical therapies in inflammatory bowel disease Am J Gastroenterol 106 Suppl 1 2011 S2 S25
6. W.J. Sandborn, P. Rutgeerts, and B.G. Feagan colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab Gastroenterology 137 2009 1250 1260
7. B.G. Feagan, P. Rutgeerts, and B.E. Sands Vedolizumab as induction and maintenance therapy for ulcerative colitis N Engl J Med 369 2013 699 710
8. S. Danese New therapies for inflammatory bowel disease: from the bench to the bedside Gut 61 2012 918 932
9. J. Torres, S. Danese, and J.-F. Colombel New therapeutic avenues in ulcerative colitis: thinking out of the box Gut 62 2013 1642 1652
10. S. Michail, M. Durbin, and D. Turner Alterations in the gut microbiome of children with severe ulcerative colitis Inflamm Bowel Dis 18 2012 1799 1808
11. S. Nell, S. Suerbaum, and C. Josenhans The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models Nat Rev Microbiol 8 2010 564 577
12. E. van Nood, A. Vrieze, and M. Nieuwdorp Duodenal infusion of donor feces for recurrent clostridium difficile N Engl J Med 368 2013 407 415
13. P. Moayyedi, J.K. Marshall, and Y. Yuan Canadian Association of Gastroenterology position statement: fecal microbiota transplant therapy Can J Gastroenterol 28 2014 66 68
14. J.L. Anderson, R.J. Edney, and K. Whelan Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease Aliment Pharmacol Ther 36 2012 503 516
15. S. Angelberger, W. Reinisch, and A. Makristathis Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation Am J Gastroenterol 108 2013 1620 1630
16. G. D'Haens, W.J. Sandborn, and B.G. Feagan A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis Gastroenterology 132 2007 763 786
17. E.J. Irvine, B. Feagan, and J. Rochon Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease Gastroenterology 106 1994 287 296
18. H.H. Konig, A. Ulshofer, and M. Gregor Validation of the EuroQol questionnaire in patients with inflammatory bowel disease Eur J Gastroenterol Hepatol 14 2002 1205 1215
19. F.J. Whelan, C.P. Verschoor, and J.C. Stearns The loss of topography in the microbial communities of the upper respiratory tract in the elderly Ann Am Thorac Soc 11 2014 513 521
20. A.K. Bartram, M.D.J. Lynch, and J.C. Stearns Generation of multimillion-sequence 16S rRNA gene libraries from complex microbial communities by assembling paired-end illumina reads Appl Environ Microbiol 77 2011 3846 3852
21. P.J. McMurdie, and S. Holmes phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data PLoS One 8 2013 e61217
22. J.G. Caporaso, J. Kuczynski, and J. Stombaugh QIIME allows analysis of high-throughput community sequencing data Nat Methods 7 2010 335 336
23. A.C. Ford, J.P. Achkar, and K.J. Khan Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis Am J Gastroenterol 106 2011 601 616
24. W. Reinisch, W.J. Sandborn, and D.W. Hommes Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial Gut 60 2011 780 787
25. Z. Kassam, C.H. Lee, and Y. Yuan Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis Am J Gastroenterol 108 2013 500 508
26. L.J. Brandt American Journal of Gastroenterology Lecture: intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection Am J Gastroenterol 108 2013 177 185
27. K.J. Khan, T.A. Ullman, and A.C. Ford Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis Am J Gastroenterol 106 2011 661 673
28. T.J. Borody, L.J. Brandt, and S. Paramsothy Therapeutic faecal microbiota transplantation: current status and future developments Curr Opin Gastroenterol 30 2014 97 105
29. M.J. Hamilton, A.R. Weingarden, and M.J. Sadowsky Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection Am J Gastroenterol 107 2012 761 767
30. I. Youngster, G.H. Russell, and C. Pindar Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection JAMA 312 2014 1772 1778
31. M. Rajilic-Stojanovic, F. Shanahan, and F. Guarner Phylogenetic analysis of dysbiosis in ulcerative colitis during remission Inflamm Bowel Dis 19 2013 481 488
32. Z. Kassam, R. Hundal, and J.K. Marshall Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection Arch Inter Med 172 2012 191 193